http://www.unboundmedicine.com/medline/ebm/research/ibandronateUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19925378/full_citation/Is_there_a_role_for_ibandronate_in_the_treatment_of_prostate_cancer_patients_with_bony_metastasesMorgan C, Wagstaff J 
Is there a role for ibandronate in the treatment of prostate cancer patients with bony metastases? [JOURNAL ARTICLE]
Acta Oncol 2009; 48(6):882-889.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19911667/full_citation/[Anti_fracture_efficacy_of_intravenous_ibandronate:_how_to_translate_epidemiological_studies_into_daily_clinical_practice]Neuprez A, Hiligsmann M, Bruyère O, et al. 
[Anti-fracture efficacy of intravenous ibandronate: how to translate epidemiological studies into daily clinical practice] [English Abstract, Journal Article]
Rev Med Liege 2009 Oct; 64(10):525-9.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19909829/full_citation/Effects_of_intermittent_intravenous_ibandronate_injections_on_bone_quality_and_micro_architecture_in_women_with_postmenopausal_osteoporosis:_the_DIVA_study_Recker RR, Ste-Marie LG, Langdahl B, et al. 
Effects of intermittent intravenous ibandronate injections on bone quality and micro-architecture in women with postmenopausal osteoporosis: the DIVA study. [JOURNAL ARTICLE]
Bone 2009 Nov 9.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19898839/full_citation/Prescription_of_anti_osteoporosis_drugs_during_2004_2007_a_nationwide_register_study_in_Norway_Devold HM, Doung GM, Tverdal A, et al. 
Prescription of anti-osteoporosis drugs during 2004-2007-a nationwide register study in Norway. [JOURNAL ARTICLE]
Eur J Clin Pharmacol 2009 Nov 7.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19894333/full_citation/Safety_and_antisorptive_power_of_Ibandronate_applied_in_the_real_life_setting_Bunyaratavej N, Wajanavisit W, Pauvilai P, et al. 
Safety and antisorptive power of Ibandronate applied in the real-life setting. [Journal Article, Research Support, Non-U.S. Gov't]
J Med Assoc Thai 2009 Sep.:S72-5.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19855926/full_citation/Infusion_of_ibandronate_once_every_3_months_effectively_decreases_bone_resorption_markers_and_increases_bone_mineral_density_in_Chinese_postmenopausal_osteoporotic_women:_a_1_year_study_Li M, Xing XP, Zhang ZL, et al. 
Infusion of ibandronate once every 3 months effectively decreases bone resorption markers and increases bone mineral density in Chinese postmenopausal osteoporotic women: a 1-year study. [JOURNAL ARTICLE]
J Bone Miner Metab 2009 Oct 24.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19851511/full_citation/Gastrointestinal_tolerability_with_ibandronate_after_previous_weekly_bisphosphonate_treatment_Derman R, Kohles JD, Babbitt A 
Gastrointestinal tolerability with ibandronate after previous weekly bisphosphonate treatment. [Journal Article]
Clin Interv Aging 2009.:357-65.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19845802/full_citation/Osteoporosis_management:_a_perspective_based_on_bisphosphonate_data_from_randomised_clinical_trials_and_observational_databases_Boonen S, Kay R, Cooper C, et al. 
Osteoporosis management: a perspective based on bisphosphonate data from randomised clinical trials and observational databases. [JOURNAL ARTICLE]
Int J Clin Pract 2009 Oct 20.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19835464/full_citation/Update_on_monthly_oral_bisphosphonate_therapy_for_the_treatment_of_osteoporosis:_focus_on_ibandronate_150_mg_and_risedronate_150_mg_Epstein S, Jeglitsch M, McCloskey E 
Update on monthly oral bisphosphonate therapy for the treatment of osteoporosis: focus on ibandronate 150 mg and risedronate 150 mg. [JOURNAL ARTICLE]
Curr Med Res Opin 2009 Oct 16.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19824126/full_citation/Pricey_osteoporosis_remedy_doesn't_beat_older_drugs_Pricey osteoporosis remedy doesn't beat older drugs. [Journal Article]
Consum Rep 2009 Aug; 74(8):19.
Full Citation | Find Related Articles